Navigation Links
GoInformatics and TeselaGen to Partner on Scientific Data Management Solution
Date:11/15/2013

th industry we have built a very economical R&D infrastructure that adds a great deal of real-world value. We think the time is ripe for all of biotech to take advantage of advanced cloud-based tools for their high-value R&D and research CRO management activities. Byte for Byte we generate some of the most valuable data in the world, encoding the next blockbuster drug or high value chemical. Having a LIMS partner like GoInformatics with a nearly identical technology stack will make integration and security provisioning a much easier proposition."

"TeselaGen's experience and capabilities in automated biomolecule design are of enormous value to our clients and prospects", said Chad Gregory, CEO, GoInformatics. "We work closely with biotech companies in RNAi therapeutics, crop science, and animal health and nutrition space where TeselaGen's bioCAD/CAM rapid prototyping tools can be of tremendous value. One of our key initiatives for this year was to find a strategic partner to compliment our product and services and bring meaningful analytical biotechnology tools to our solution set. In TeselaGen we found the ideal partner as both companies are very passionate about helping R&D organizations get more out of their spending and resources by implementing better scientific and technology infrastructures."

About GoInformatics
GoInformatics is a privately held company based in South Bend, IN. The company provides Scientific Data Management tools and services for research and development groups. GoInformatics software solutions were built from the ground up as an exclusively cloud-based technology for research collaboration and organization, intellectual property protection, and regulatory compliance. Since its official launch, GoInformatics' GoLIMS platform has been licensed and adopted by academic institutions and biotech companies around the world. The company's tools have been implemente
'/>"/>

SOURCE GoInformatics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. WuXi PharmaTech to Partner with Pharmacyclics
2. Cell Therapeutics to Host Conference Call Today, Friday, November 15, 2013, at 8:30 a.m. Eastern Time, to Discuss Pacritinib Partnership
3. Argos Therapeutics to Present at the Elsevier Therapeutic Area Partnerships Meeting
4. Unique Partnership Lights Up a Parkinsons Disease Research Tool
5. Edith Sanford Breast Cancer Foundation Named Official Charity Partner of Womens Running Series
6. Ventana to partner with Incyte on the development of Companion Diagnostic tests
7. Liaison Healthcare and PointClickCare Partner for Lab Connectivity & Interoperability
8. G1 Therapeutics to Present at Southeast BIO Investor & Partnering Forum
9. SONIFI Healthcare And Insignia Health Partnering To Enhance Patient Engagement
10. HighPoint Solutions and InnoPeritus Partner to Provide Unprecedented Consultative Services in the European Life Sciences Market
11. ECRI Institute PSO and ISMP Partner on PSO Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... ZIONA, Israel , June 29, ... BVXV, TASE: BVXV) today announced positive preliminary results from ... candidate for a universal influenza vaccine. In this trial, ... of 50 to 65, followed by an administration of ... later. M-001 was found to be safe and well ...
(Date:6/29/2015)... Calif. , June 29, 2015  Isis Pharmaceuticals, ... has been added to the Russell 1000 Index, effective ... performance of the large-cap segment of the U.S. equity ... Index and includes approximately 1000 of the largest securities ... current index membership. "We are pleased to ...
(Date:6/29/2015)... Calif. , June 29, 2015  Arbor ... medical workstation lineup. The high-powered, multi-functional M2150 ... generation Intel® Haswell Core i5-4402E 1.6 ... provide significant data processing and computing performance. Integrated ... making the unit well suited for graphics-intense applications ...
Breaking Medicine Technology:BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 3ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3
... Ouchless ® Needle by BellaNovus Development Company ... Dr. Mariano Busso is the latest in a growing ... its use for cosmetic injections. Dr. Busso is on ... localized pain resulting from cosmetic injections. Ouchless ® ...
... a critical care company focused on developing and commercializing ... the U.S. Food and Drug Administration (FDA) has granted ... oxide (iNO) with the INOpulse® DS drug-delivery system as ... investigational new drug application (IND) for PAH was submitted ...
Cached Medicine Technology:New Ouchless® Needle Collection Announces Leading Dermatology Testimonial 2FDA Grants Orphan Drug Designation to Ikaria® For Use of Inhaled Nitric Oxide in Pulmonary Arterial Hypertension 2FDA Grants Orphan Drug Designation to Ikaria® For Use of Inhaled Nitric Oxide in Pulmonary Arterial Hypertension 3FDA Grants Orphan Drug Designation to Ikaria® For Use of Inhaled Nitric Oxide in Pulmonary Arterial Hypertension 4
(Date:6/29/2015)... ... June 29, 2015 , ... ... series as part of its support program. This discussion series is part of ... other support services to those affected by mesothelioma. , The six week discussion ...
(Date:6/29/2015)... ... 2015 , ... The Society for Immunotherapy of Cancer (SITC) ... accelerated approval of Bristol-Myers Squibb’s Opdivo® (nivolumab) for the treatment of metastatic melanoma. ... nivolumab for patients with metastatic melanoma in Europe represents a major advance in ...
(Date:6/29/2015)... , ... June 29, 2015 , ... ... now being offered at NewYork-Presbyterian/Weill Cornell Medical Center. The device is the first ... an alternative to continuous positive airway pressure (CPAP), the current standard of care ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... , **FDAnews Webinar**, July 16, 2015 — 1:30 p.m. – 3:00 p.m. EDT, ... application of human factors engineering to the design of new products as well ...
(Date:6/29/2015)... York, NY (PRWEB) , ... June 29, 2015 ... ... Mount Sinai have developed a new approach to build nearly complete genomes by ... complex forms of genomic variation, critically important for their association with human disease, ...
Breaking Medicine News(10 mins):Health News:Mesothelioma Organization Provides Support for Patients and Families 2Health News:Mesothelioma Organization Provides Support for Patients and Families 3Health News:Society for Immunotherapy of Cancer Reacts to EMA Approval of Nivolumab for Treatment of Metastatic Melanoma 2Health News:Society for Immunotherapy of Cancer Reacts to EMA Approval of Nivolumab for Treatment of Metastatic Melanoma 3Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 2Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 3Health News:NewYork-Presbyterian/Weill Cornell Medical Center Is First in New York to Offer New Alternative Treatment for Sleep Apnea 4Health News:FDAnews Announces Human Factors and Usability Studies: Understanding and Optimizing Interaction with Medical Devices Webinar, July 16, 2015 2Health News:FDAnews Announces Human Factors and Usability Studies: Understanding and Optimizing Interaction with Medical Devices Webinar, July 16, 2015 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 2Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 4
... , , , , , ... AUDIO: Scientists at Washington University School of Medicine in St. Louis have found a ... Click here for more information. , , , ... , , , , , ...
... European Society of Cardiology (ESC) is concerned that interpretations ... Lancet (1), could act to deter ongoing research ... density lipoprotein (HDL) cholesterol. Caution, the ESC experts ... results. In the Lancet study, Paul ...
... of the global AIDS community concluded today with clear ... scale up, yet facing an urgent need for increased ... of ,scientifically sound prevention strategies. Delegates and organizers depart ... the theme of Rights Here, Right Now -- with ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, July ... airborne fungus that can cause life-threatening illness -- is an ... Thursday. While C. gattii infections are rare ... they can be severe and even fatal, researchers at the ...
... THURSDAY, July 22 (HealthDay News) -- In small theater ... learning that acting can be a powerful form of therapy, ... deeply personal accounts of mental health issues. "Theater arts ... piece their lives back together," said David A. Faigin, department ...
... happy hour. He sidles up to the bar and orders a ... drink yourself? According to new findings reported in Psychological Science ... determine the extent to which you are influenced by social drinking ... and seeing other people around you drinking. Drinking alcohol increases ...
Cached Medicine News:Health News:Inhibiting fatty acids in immune cells decreases atherosclerosis risk 2Health News:Inhibiting fatty acids in immune cells decreases atherosclerosis risk 3Health News:Inhibiting fatty acids in immune cells decreases atherosclerosis risk 4Health News:No firm conclusions about HDL cholesterol can be drawn from JUPITER sub-analysis 2Health News:No firm conclusions about HDL cholesterol can be drawn from JUPITER sub-analysis 3Health News:Strong scientific findings presented at AIDS 2010 point to promise ahead and underscore the need to stay the course 2Health News:Strong scientific findings presented at AIDS 2010 point to promise ahead and underscore the need to stay the course 3Health News:Strong scientific findings presented at AIDS 2010 point to promise ahead and underscore the need to stay the course 4Health News:Dangerous Fungus Now Endemic in Pacific Northwest: CDC 2Health News:Dangerous Fungus Now Endemic in Pacific Northwest: CDC 3Health News:Taking to the Stage to Battle Mental Illness 2Health News:Taking to the Stage to Battle Mental Illness 3Health News:Taking to the Stage to Battle Mental Illness 4Health News:Can I buy you a drink? Genetics may determine sensitivity to other people's drinking behavior 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: